SCHEMBL4386915

SCHEMBL4386915

CCc1c(OCOC)cc(OCOC)c(-c2ccccc2)c1CCOCC(=O)N(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.36
POLB P06746 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 4/20 0.34
HSD17B10 Q99714 3/20 0.34
MAPK1 P28482 1/20 0.34
KDM4E B2RXH2 2/20 0.33
HPGD P15428 2/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
RECQL P46063 1/20 0.33
FABP3 P05413 2/20 0.32
FABP4 P15090 2/20 0.32
FABP5 Q01469 1/20 0.32
TSHR P16473 1/20 0.32
KEAP1 Q14145 1/20 0.31
NFE2L2 Q16236 1/20 0.31
PDCD1 Q15116 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4381037 0.94 EGFR (0.35) EGFRPOLBSMN1; SMN2ALDH1A1HSD17B10
SCHEMBL4380935 0.89 EGFR (0.39) EGFRPOLBSMN1; SMN2GLAFABP3
SCHEMBL4380474 0.88 DPP4 (0.39) EGFRKDM4EFABP3FABP4FABP5
SCHEMBL4392320 0.86 EGFR (0.36) EGFRSMN1; SMN2ALDH1A1HPGDNPC1
SCHEMBL4382068 0.84 EGFR (0.35) EGFRSMN1; SMN2
SCHEMBL4378212 0.83 EGFR (0.38) EGFRPOLBSMN1; SMN2GLAFABP3
SCHEMBL4387419 0.83 EGFR (0.38) EGFRSMN1; SMN2ALDH1A1MAPK1KDM4E
SCHEMBL4379642 0.82 EGFR (0.37) EGFRKDM4E
SCHEMBL4384888 0.82 DPP4 (0.39) EGFRFABP3FABP4FABP5
SCHEMBL4378977 0.81 EGFR (0.37) EGFRPOLBSMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed
EP-1704856-A1 HSP90 FAMILY PROTEIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P EGFR 624/4885POLB 3913/4885SMN1; SMN2 4471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.